| __timestamp | Amphastar Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 117418000 |
| Thursday, January 1, 2015 | 174172000 | 102526000 |
| Friday, January 1, 2016 | 150976000 | 105386000 |
| Sunday, January 1, 2017 | 149380000 | 110188000 |
| Monday, January 1, 2018 | 187681000 | 121544000 |
| Tuesday, January 1, 2019 | 190434000 | 127930000 |
| Wednesday, January 1, 2020 | 206506000 | 148917000 |
| Friday, January 1, 2021 | 238029000 | 440760000 |
| Saturday, January 1, 2022 | 250127000 | 540517000 |
| Sunday, January 1, 2023 | 293274000 | 435577000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc. have shown distinct trends in their cost of revenue from 2014 to 2023. Amphastar's cost of revenue has steadily increased by approximately 84%, peaking at 293 million in 2023. In contrast, Jazz Pharmaceuticals experienced a dramatic surge in 2021, with costs rising by 296% compared to 2020, reaching a high of 541 million in 2022. This spike reflects strategic investments or operational shifts. However, by 2023, Jazz's costs slightly decreased by 19%, indicating potential efficiency improvements or market adjustments. These trends highlight the dynamic nature of cost management in the pharmaceutical industry, where companies must balance growth with operational efficiency. Understanding these patterns provides valuable insights into the financial strategies of leading pharmaceutical firms.
Cost Insights: Breaking Down AbbVie Inc. and Jazz Pharmaceuticals plc's Expenses
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
Analyzing Cost of Revenue: GSK plc and Amphastar Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Vericel Corporation
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs Galapagos NV
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.